Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Hever Navarro-Quero"'
Autor:
Wenche Jy, Ashish K. Rehni, Carlos Bidot, Hever Navarro-Quero, Conner R. Haase, Sebastian Koch, Yeon S. Ahn, Kunjan R. Dave
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Red blood cell microparticles (RMPs) is a high potency hemostatic agent, which may serve as a viable therapeutic approach. They generate thrombin in vitro and effective in arresting bleeding in animal bleeding models. However, prior to ascertaining t
Externí odkaz:
https://doaj.org/article/13fd8fb5720f407a9d91ddc79ff20c38
Autor:
Ashish K. Rehni, Sunjoo Cho, Hever Navarro Quero, Vibha Shukla, Zhexuan Zhang, Chuanhui Dong, Weizhao Zhao, Miguel A. Perez-Pinzon, Sebastian Koch, Wenche Jy, Kunjan R. Dave
Publikováno v:
Stroke. 53:3182-3191
Background: Spontaneous intracerebral hemorrhage (sICH) is the deadliest stroke subtype with no effective therapies. Limiting hematoma expansion is a promising therapeutic approach. Red blood cell-derived microparticles (RMPs) are novel hemostatic ag
Autor:
Ashish K. Rehni, Sunjoo Cho, Hever Navarro Quero, Zhexuan Zhang, Chuanhui Dong, Weizhao Zhao, Miguel A. Perez-Pinzon, Sebastian Koch, Wenche Jy, Kunjan R. Dave
Publikováno v:
Stroke. 54
Autor:
Carlos J. Bidot, Ashish K. Rehni, Kunjan R. Dave, Conner R. Haase, Sebastian Koch, Wenche Jy, Vibha Shukla, Yeon S. Ahn, Hever Navarro Quero, Ensign Anise A. Crane, Shivam Patel
Publikováno v:
J Cardiovasc Pharmacol Ther
Background:Uncontrollable bleeding is a major cause of mortality and morbidity worldwide. Effective hemostatic agents are urgently needed. Red cell microparticles (RMPs) are a highly promising hemostatic agent. This study evaluated the safety profile
Autor:
Kunjan R. Dave, Hever Navarro Quero, Sunjoo Cho, Ashish K. Rehni, Miguel A. Perez-Pinzon, Ami P. Raval
Publikováno v:
Stroke. 52
Spontaneous intracerebral hemorrhage (sICH) is the deadliest stroke subtype. There is strong evidence that tobacco use / smoking increases the risk of sICH, and some epidemiological studies have observed sex differences in sICH outcomes. However, sys
Autor:
Sebastian Koch, Sunjoo Cho, Wenche Jy, Kunjan R. Dave, Hever Navarro Quero, Yeon S. Ahn, Miguel A. Perez-Pinzon, Ashish K. Rehni
Publikováno v:
Stroke. 51
Spontaneous intracerebral hemorrhage (sICH) is a serious form of stroke without any effective therapy. Limiting hematoma growth is a promising therapeutic strategy. Published data showed that red blood cell-derived microparticles (RMPs) enhance both
Autor:
Weizhao Zhao, Sunjoo Cho, Hever Navarro Quero, Zhexuan Zhang, Kunjan R. Dave, Ashish K. Rehni
Publikováno v:
Transl Stroke Res
Simulating a clinical condition of intracerebral hemorrhage (ICH) in animals is key to research on the development and testing of diagnostic or treatment strategies for this high-mortality disease. In order to study the mechanism, pathology, and trea
Autor:
Yeon S. Ahn, Miguel A. Perez-Pinzon, Kunjan R. Dave, Hever Navarro Quero, Ashish K. Rehni, Sebastian Koch, BidotCarlos, Wenche Jy, Vibha Shukla
Publikováno v:
Stroke. 50
Currently there is no effective treatment for spontaneous intracerebral hemorrhage (sICH). Limiting hematoma extension in sICH is an attractive therapeutic target. Earlier studies demonstrated that red blood cell-derived microparticles (RMP) enhance
Autor:
Rehni, Ashish K., Shukla, Vibha, Hever Navarro Quero, Bidot, Carlos, Haase, Conner R., Ensign Anise A. Crane, Shivam G. Patel, Koch, Sebastian, Ahn, Yeon S., Jy, Wenche, Kunjan R. Dave
Supplementary_section for Preclinical Evaluation of Safety and Biodistribution of Red Cell Microparticles: A Novel Hemostatic Agent by Ashish K. Rehni, Vibha Shukla, Hever Navarro Quero, Carlos Bidot, Conner R. Haase, Ensign Anise A. Crane, Shivam G.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::088488292920e64cf370d2bcf3ba7058
Autor:
Hever Navarro-Quero, Shivam Patel, Vibha Shukla, Carlos J. Bidot, Sebastian Koch, Wenche Jy, Ashish K. Rehni, Anise Crane, Conner R. Haase, Kunjan R. Dave, Yeon S. Ahn
Publikováno v:
Blood. 132:1044-1044
BACKGROUND: Uncontrollable bleeding is a major cause of mortality and morbidity worldwide. Effective hemostatic agents are urgently needed. Red cell microparticles (RMP) have been introduced as a promising new hemostatic agent [Thromb Haemost 2013, 1